Comparative clinical assessment in post menopausal syndrome by unani formulation.

Clinical efficacy of Habb-e-asgandh wa Habb-e-matwareedi in post menopausal syndrome (Mutalazma bad -azInqat-e-Tams)-A Randomised comparative single blind trial - No

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/086065

Enrollment

Registered

2025-04-30

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N951- Menopausal and female climactericstates Health Condition 2: N951- Menopausal and female climactericstates

Interventions

Intervention1: Habb-e- marwareed: 2 tablets of 250 mg each will be given twice a day with plane water Intervention2: Habb-e-Marwareedi: 2 tablets of 100 to 125 mg each will be given twice a day with p

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed patient with post menopausal syndrome. And willing to participate in study. Patient presenting with one or more than one menopausal symptoms. Patient selected age group 45 to 60 year.

Exclusion criteria

Exclusion criteria: Patient below age of 40 or above the age of 60 years. Patient suffering from Diabetes mellitus, hyper parathyroidism paget s disease thyrotoxicosis, endocrinal disorders and other systematic disease were excluded. Patient with systemic illness, with the past history of taken HRT within 2 months.

Design outcomes

Primary

Measure	Time frame
HRQoL measurement (MRS Questionnaire) menopausal rating scale consisted of 11 items assessing menopausal symptoms divided in three subscale: A: somatic: Hot flushes, heat discomfort, sleep problems, joint & muscles problems. B: psychological: Depression, irritability, anxity,and physical &mrntal exhaustion C: Urogenital: sexual problems, bladder problems, and dryness in vagina. A 5 point rating scale permit the patient to describe the perceived severity of complaints graded from 0-4, (0= Not present), (1= mild), (2=morderte), (3=severe),(4=very severe) By checking the approptiate box .for the present study the MRS English version was used. The composite score for each of the subscale is based on adding up the score of the items of the respective dimension scale.Timepoint: At 15th day at 30th day at 30th day at 45th day at 60th day	—

Measure

Time frame

HRQoL measurement (MRS Questionnaire) menopausal rating scale consisted of 11 items assessing menopausal symptoms divided in three subscale: A: somatic: Hot flushes, heat discomfort, sleep problems, joint & muscles problems. B: psychological: Depression, irritability, anxity,and physical &mrntal exhaustion C: Urogenital: sexual problems, bladder problems, and dryness in vagina. A 5 point rating scale permit the patient to describe the perceived severity of complaints graded from 0-4, (0= Not present), (1= mild), (2=morderte), (3=severe),(4=very severe) By checking the approptiate box .for the present study the MRS English version was used. The composite score for each of the subscale is based on adding up the score of the items of the respective dimension scale.Timepoint: At 15th day at 30th day at 30th day at 45th day at 60th day

—

Secondary

Measure	Time frame
Life quality index Breff scaleTimepoint: At 15th day at 30th day at 30th day at 45th day at 60th day	—

Countries

India

Contacts

Public ContactDr Aysha Mohammadi

Ayurvedic and Unani Tibbia College Karol bagh Delhi

draysharaza11@gmail.com9354925031

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026